Federal judge to hear testimony on CVS-Aetna merger settlement

The federal judge reviewing an agreement between the government and CVS Health, which allowed the pharmacy chain to purchase Aetna, said April 5 he wants to hold a hearing for opponents of the deal, according to Reuters.

Advertisement

In a recent court hearing, Judge Richard Leon of the U.S. District Court for the District of Columbia said he plans to listen to critics of the deal in May. The American Medical Association, AIDS Healthcare Foundation, and other pharmacy and consumer groups have spoken out against the deal.

While the Justice Department approved the $70 billion CVS-Aetna deal in October 2018, and the transaction closed in November of the same year, Mr. Leon is tasked with approving the department’s consent decree on the merger. This process is often completed without pushback, but Mr. Leon was not as convinced the department’s agreement with the company alleviated antitrust concerns. 

More articles on payers:
BCBS of Texas to open primary care clinics: 5 things to know
128,000 kids lost health insurance in Tennessee over 2 years — Here’s why
Pennsylvania woman denied coverage for sepsis-related foot amputation

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.